Evidence map›Paper›PMID 42723478›Full record

ReviewJournal of extracellular vesicles2026

Natural Product-Derived Vesicles in Nanotherapeutics.

Kartiko Arif Purnomo, Tsong-Long Hwang

Abstract readReview
In one paragraph

Review in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kartiko Arif PurnomoCenter for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan, Taiwan.ORCID 0000-0003-0858-5368
Tsong-Long HwangCenter for Drug Research and Development, Chang Gung University of Science and Technology, Taoyuan, Taiwan.ORCID 0000-0002-5780-3977

Funding

Chang Gung Memorial Hospital CMRPF1P0102Chang Gung Memorial Hospital CMRPF3Q0011Chang Gung Memorial Hospital CORPF1P0071-3Chang Gung University of Science and Technology ZRRPF3M0091Chang Gung University of Science and Technology ZRRPF3P0091National Science and Technology Council 114-2321-B-255-001National Science and Technology Council 114-2811-B-255-004
6 · The paper itself

Abstract

Natural product-derived vesicles (NPVs) are lipid bilayer-enclosed nanovesicles isolated from diverse sources, including plants, fungi, and marine organisms, and are increasingly recognized as an emerging class of extracellular vesicles with potential therapeutic relevance. Their abundance, renewability, and capacity to transport endogenous metabolites and exogenous cargoes highlight their potential as scalable biological delivery vehicles. NPVs can interact with mammalian cells, participate in intercellular communication, and influence conserved biological pathways that modulate disease, support tissue repair, and maintain cellular homeostasis. In addition, their structural plasticity provides opportunities for physicochemical optimization to improve functional performance and targeting properties. However, the development and translation of NPVs are constrained by challenges, including heterogeneity, variability in isolation procedures, and insufficient physicochemical and functional characterization. This review presents a systematic framework encompassing source identification, purification strategies, and characterization methods, while integrating separation approaches with multifaceted assessments to facilitate the rational development of NPVs, with particular emphasis on recent advances in structural optimization and therapeutic efficacy. Furthermore, the status of nine clinical trials is highlighted, reflecting the growing translational and therapeutic potential of NPVs. By delineating current limitations and discussing potential solutions, this review provides practical guidance for improving the physicochemical consistency and biological performance of NPVs, thereby facilitating their development as nature-inspired nanotherapeutic systems.

Indexed as

Biological ProductsExtracellular VesiclesNanomedicineAnimalsDrug Delivery SystemsHumansBiological Productsextracellular vesiclesnanotherapeuticsnanovesiclesnatural product‐derived vesiclesnatural productsplant‐derived nanovesicles

Identifiers

PMID42723478
PMCPMC13563072

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.